Therefore, we reasonably hypothesized that GPX3, in STAD, may influence the level of pyrimidine metabolism by regulating the amount of ROS in the organism and this is mediated by the AMPK/mTOR signaling pathway (Figure 10(b)). The gene discussed is GPX3; the disease is gastric adenocarcinoma.